Header Logo

Cynthia I Campbell PhD, MPH

TitleResearch Scientist III
InstitutionKaiser Permanente Northern California
DepartmentDivision of Research
Address2000 Broadway
Oakland CA 94612
ORCID ORCID Icon0000-0003-1019-5852 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San DiegoB.A.06/1989Psychology
    University of California, Los AngelesM.P.H.06/1997Health Services
    University of Michigan, Ann ArborPh.D.03/2003Health Services, Organization, and Policy
    University of California, San FranciscoPostdoctoral Fellowship2006Substance Abuse and Health Services

    Collapse Overview 
    Collapse overview
    Dr. Cynthia Campbell is a research scientist at the Division of Research, Kaiser Permanente Northern California, conducting research on the treatment of substance use and mental health problems. She is also an Adjunct Associate Professor in the Department of Psychiatry, University of California, San Francisco. Her interests include access to treatment, chronic pain and substance use, prescription opioid use and misuse, adolescent behavioral health, benefit design and cost sharing, and organizational factors and policy related to these areas. She is currently the principal investigator of a NIDA-funded study examining the impact of the ACA on addiction and HIV services, a NIDA-funded study examining substance use service intensity for buprenorphine patients, and a PCORI-funded study of a patient activation intervention in primary care for chronic pain patients starting long-term prescription opioid use. Her work also includes the assessment of attention deficit hyperactivity disorder (ADHD) in children. She received her doctorate in Public Health at the University of Michigan, and conducted her postdoctoral work at UCSF in a NIDA-funded fellowship on Substance Abuse and Health Services.

    Collapse Research 
    Collapse research activities and funding
    UG1DA040314     (CAMPBELL, CYNTHIA I)Sep 1, 2015 - May 31, 2020
    NIH/NIDA
    Integrating Addiction Research in Health Systems: The Addiction Research Network
    Role: Principal Investigator

    R01DA036603     (CAMPBELL, CYNTHIA I)Sep 15, 2014 - Aug 31, 2018
    NIH/NIDA
    Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
    Role: Principal Investigator

    R33DA035645     (SATRE, DEREK D.)May 1, 2013 - Apr 30, 2018
    NIH/NIDA
    The Impact of Health Care Reform on Addiction and HIV Services
    Role: Principal Investigator

    R21DA035645     (SATRE, DEREK D.)May 1, 2013 - Apr 30, 2014
    NIH/NIDA
    The Impact of Health Care Reform on Addiction and HIV Services
    Role: Co-Principal Investigator

    R01DA030438     (CAMPBELL, CYNTHIA I)Sep 15, 2011 - Aug 31, 2014
    NIH/NIDA
    High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories
    Role: Principal Investigator

    R01AA018142     (CAMPBELL, CYNTHIA I)May 20, 2010 - Apr 30, 2013
    NIH/NIAAA
    Alcohol Trajectories and Service Use in Young Adults: Nine Years Post Treatment
    Role: Principal Investigator

    R21AA016326     (CAMPBELL, CYNTHIA I)Aug 1, 2007 - Jul 31, 2010
    NIH/NIAAA
    Patients with Alcohol Problems and Chronic Pain: Use of Alcohol and Pain Services
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lu Y, Chi FW, Parthasarathy S, Palzes VA, Kline-Simon AH, Metz VE, Weisner C, Satre DD, Campbell CI, Elson J, Ross TB, Awsare SV, Sterling SA. Patient and provider factors associated with receipt and delivery of brief interventions for unhealthy alcohol use in primary care. Alcohol Clin Exp Res. 2021 Sep 05. PMID: 34486124.
      Citations:    
    2. Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA, PROUD Collaborative. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. Addict Sci Clin Pract. 2021 07 07; 16(1):46. PMID: 34233750; PMCID: PMC8262000.
      Citations:    
    3. Rao K, Carpenter DM, Campbell CI. Attention-Deficit/Hyperactivity Disorder Medication Adherence in the Transition to Adulthood: Associated Adverse Outcomes for Females and Other Disparities. J Adolesc Health. 2021 May 28. PMID: 34059427.
      Citations:    
    4. Matson TE, Carrell DS, Bobb JF, Cronkite DJ, Oliver MM, Luce C, Ghitza UE, Hsu CW, Campbell CI, Browne KC, Binswanger IA, Saxon AJ, Bradley KA, Lapham GT. Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State. JAMA Netw Open. 2021 May 03; 4(5):e219375. PMID: 33956129; PMCID: PMC8103224.
      Citations:    
    5. Ridout KK, Alavi M, Ridout SJ, Koshy MT, Harris B, Dhillon I, Awsare S, Weisner CM, Campbell CI, Iturralde E. Changes in Diagnostic and Demographic Characteristics of Patients Seeking Mental Health Care During the Early COVID-19 Pandemic in a Large, Community-Based Health Care System. J Clin Psychiatry. 2021 03 03; 82(2). PMID: 33979485.
      Citations:    
    6. Tsui JI, Akosile MA, Lapham GT, Boudreau DM, Johnson EA, Bobb JF, Binswanger IA, Yarborough BJH, Glass JE, Rossom RC, Murphy MT, Cunningham CO, Arnsten JH, Thakral M, Saxon AJ, Merrill JO, Samet JH, Bart GB, Campbell CI, Loree AM, Silva A, Stotts AL, Ahmedani B, Braciszewski JM, Hechter RC, Northrup TF, Horigian VE, Bradley KA. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. J Gen Intern Med. 2021 04; 36(4):930-937. PMID: 33569735; PMCID: PMC8041979.
      Citations:    
    7. Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Glass JE, Lapham GT, Murphy SM, Weinstein ZM, Yarborough BJH, Bradley KA. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9. PMID: 33517894; PMCID: PMC7849121.
      Citations:    
    8. Karnik NS, Campbell CI, Curtis ME, Fiellin DA, Ghitza U, Hefner K, Hser YI, McHugh RK, Murphy SM, McPherson SM, Moran L, Mooney LJ, Wu LT, Shmueli-Blumberg D, Shulman M, Schwartz RP, Stephens KA, Watkins KE, Marsden J. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study. Trials. 2021 Jan 28; 22(1):102. PMID: 33509278; PMCID: PMC7841754.
      Citations:    
    9. Satre DD, Iturralde E, Ghadiali M, Young-Wolff KC, Campbell CI, Leibowitz AS, Sterling SA. Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies. J Addict Med. 2020 12; 14(6):e293-e296. PMID: 33156267; PMCID: PMC7892198.
      Citations:    
    10. Satre DD, Parthasarathy S, Silverberg MJ, Horberg M, Young-Wolff KC, Williams EC, Volberding P, Campbell CI. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study. BMC Health Serv Res. 2020 Nov 11; 20(1):1030. PMID: 33176760; PMCID: PMC7656679.
      Citations:    
    11. Satre DD, Palzes VA, Young-Wolff KC, Parthasarathy S, Weisner C, Guydish J, Campbell CI. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system. J Subst Abuse Treat. 2020 11; 118:108097. PMID: 32972648; PMCID: PMC7519171.
      Citations:    
    12. Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJ, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter RC, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. J Subst Abuse Treat. 2020 03; 112S:41-48. PMID: 32220410; PMCID: PMC7107675.
      Citations:    
    13. Karmali RN, Ray GT, Rubinstein AL, Sterling SA, Weisner CM, Campbell CI. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose. Drug Alcohol Depend. 2020 04 01; 209:107923. PMID: 32126455; PMCID: PMC7238973.
      Citations:    
    14. Owen-Smith A, Stewart C, Sesay MM, Strasser SM, Yarborough BJ, Ahmedani B, Miller-Matero LR, Waring SC, Haller IV, Waitzfelder BE, Sterling SA, Campbell CI, Hechter RC, Zeber JE, Copeland LA, Scherrer JF, Rossom R, Simon G. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness. BMC Psychiatry. 2020 01 31; 20(1):40. PMID: 32005200; PMCID: PMC6995196.
      Citations:    
    15. Karmali RN, Bush C, Raman SR, Campbell CI, Skinner AC, Roberts AW. Long-term opioid therapy definitions and predictors: A systematic review. Pharmacoepidemiol Drug Saf. 2020 03; 29(3):252-269. PMID: 31851773; PMCID: PMC7058495.
      Citations:    
    16. Hirschtritt ME, Palzes VA, Kline-Simon AH, Kroenke K, Campbell CI, Sterling SA. Benzodiazepine and unhealthy alcohol use among adult outpatients. Am J Manag Care. 2019 12 01; 25(12):e358-e365. PMID: 31860229; PMCID: PMC7217068.
      Citations:    
    17. Liu VX, Eaton A, Lee DC, Reyes VM, Paulson SS, Campbell CI, Avins AL, Parodi SM. Postoperative Opioid Use Before and After Enhanced Recovery After Surgery Program Implementation. Ann Surg. 2019 12; 270(6):e69-e71. PMID: 31232786; PMCID: PMC7282658.
      Citations:    
    18. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD Collaborative Investigators. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732. PMID: 31835068; PMCID: PMC7158756.
      Citations:    
    19. Hedderson M, Lee D, Hunt E, Lee K, Xu F, Mustille A, Galin J, Campbell C, Quesenberry C, Reyes V, Huang M, Nicol B, Paulson S, Liu V. Enhanced Recovery After Surgery to Change Process Measures and Reduce Opioid Use After Cesarean Delivery: A Quality Improvement Initiative. Obstet Gynecol. 2019 09; 134(3):511-519. PMID: 31403591; PMCID: PMC7282661.
      Citations:    
    20. Hechter RC, Horberg MA, Weisner C, Campbell CI, Contreras R, Chen LH, Yarborough BJH, Lapham GT, Haller IV, Ahmedani BK, Binswanger IA, Kline-Simon AH, Satre DD. Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis. Subst Abus. 2019 Mar 25; 1-9. PMID: 30908174.
      Citations:    
    21. Young-Wolff KC, Adams SR, Tan ASL, Adams AS, Klebaner D, Campbell CI, Satre DD, Salloum RG, Carter-Harris L, Prochaska JJ. Disparities in knowledge and use of tobacco treatment among smokers in California following healthcare reform. Prev Med Rep. 2019 Jun; 14:100847. PMID: 31024786.
      Citations:    
    22. Kline-Simon AH, Stumbo SP, Campbell CI, Binswanger IA, Weisner C, Haller IV, Hechter RC, Ahmedani BK, Lapham GT, Loree AM, Sterling SA, Yarborough BJH. Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings. Subst Abus. 2019 Jan 31; 1-7. PMID: 30702983.
      Citations:    
    23. Loree AM, Yeh HH, Satre DD, Kline-Simon AH, Jo H Yarborough B, Haller IV, Campbell CI, Lapham GT, Hechter RC, Binswanger IA, Weisner C, Ahmedani BK. Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems. Subst Abus. 2019 Jan 25; 1-7. PMID: 30681938.
      Citations:    
    24. Weisner C, Campbell CI, Altschuler A, Yarborough BJH, Lapham GT, Binswanger IA, Hechter RC, Ahmedani BK, Haller IV, Sterling SA, McCarty D, Satre DD, Kline-Simon AH. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015. Subst Abus. 2019 Jan 24; 1-11. PMID: 30676915.
      Citations:    
    25. Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems. Subst Abus. 2019 Jan 24; 1-7. PMID: 30676931.
      Citations:    
    26. Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, McNeely J, Yarborough BJH, Kline-Simon AH, Satre DD, Weisner C, Lapham GT. The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abus. 2019 Jan 24; 1-10. PMID: 30676892.
      Citations:    
    27. Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7?US health systems. Subst Abus. 2019 Jan 18; 1-10. PMID: 30657438.
      Citations:    
    28. Young-Wolff KC, Sarovar V, Tucker LY, Avalos LA, Alexeeff S, Conway A, Armstrong MA, Weisner C, Campbell CI, Goler N. Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016. Drug Alcohol Depend. 2019 03 01; 196:66-70. PMID: 30711893.
      Citations:    
    29. Young-Wolff KC, Adams SR, Klebaner D, Adams AS, Campbell CI, Satre DD, Prochaska JJ. Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy. Med Care. 2018 11; 56(11):912-918. PMID: 30234768.
      Citations:    
    30. Samuels EA, D'Onofrio G, Huntley K, Levin S, Schuur JD, Bart G, Hawk K, Tai B, Campbell CI, Venkatesh AK. A Quality Framework for Emergency Department Treatment of Opioid Use Disorder. Ann Emerg Med. 2019 Mar; 73(3):237-247. PMID: 30318376.
      Citations:    
    31. Campbell CI, Parthasarathy S, Altschuler A, Young-Wolff KC, Satre DD. Characteristics of patients with substance use disorder before and after the Affordable Care Act. Drug Alcohol Depend. 2018 12 01; 193:124-130. PMID: 30366189.
      Citations:    
    32. Bahorik AL, Sterling SA, Campbell CI, Weisner C, Ramo D, Satre DD. Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord. 2018 12 01; 241:8-14. PMID: 30086434.
      Citations:    
    33. Yarborough BJH, Chi FW, Green CA, Hinman A, Mertens J, Beck A, Horberg M, Weisner C, Campbell CI. Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018 Jul/Aug; 12(4):278-286. PMID: 29557802.
      Citations:    
    34. Campbell CI, Bahorik AL, VanVeldhuisen P, Weisner C, Rubinstein AL, Ray GT. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018 05; 110:31-37. PMID: 29410132.
      Citations:    
    35. Ramo DE, Bahorik AL, Delucchi KL, Campbell CI, Satre DD. Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status. J Psychoactive Drugs. 2018 Jan-Mar; 50(1):43-53. PMID: 29199899.
      Citations:    
    36. Bahorik AL, Campbell CI, Sterling SA, Leibowitz A, Travis A, Weisner CM, Satre DD. Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Res. 2018 01; 259:316-322. PMID: 29100135.
      Citations:    
    37. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Young-Wolff KC, Campbell CI. Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters. Subst Abus. 2018 01 02; 39(1):59-68. PMID: 28723312.
      Citations:    
    38. Young-Wolff KC, Klebaner D, Weisner C, Von Korff M, Campbell CI. Smoking Status and Opioid-related Problems and Concerns Among Men and Women on Chronic Opioid Therapy. Clin J Pain. 2017 Aug; 33(8):730-737. PMID: 27898458.
      Citations:    
    39. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. Serious mental illness and medical comorbidities: Findings from an integrated health care system. J Psychosom Res. 2017 09; 100:35-45. PMID: 28789791.
      Citations:    
    40. Campbell CI, Bahorik AL, Kline-Simon AH, Satre DD. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175. PMID: 28651153.
      Citations:    
    41. Young-Wolff KC, Klebaner D, Campbell CI, Weisner C, Satre DD, Adams AS. Association of the Affordable Care Act With Smoking and Tobacco Treatment Utilization Among Adults Newly Enrolled in Health Care. Med Care. 2017 05; 55(5):535-541. PMID: 28288073.
      Citations:    
    42. Ray GT, Bahorik AL, VanVeldhuisen PC, Weisner CM, Rubinstein AL, Campbell CI. Prescription opioid registry protocol in an integrated health system. Am J Manag Care. 2017 May 01; 23(5):e146-e155. PMID: 28810131.
      Citations:    
    43. Campbell CI, Parthasarathy S, Young-Wolff KC, Satre DD. Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System. J Psychoactive Drugs. 2017 Apr-Jun; 49(2):160-168. PMID: 28426332.
      Citations:    
    44. Ray GT, Weisner CM, Taillac CJ, Campbell CI. The high price of depression: Family members' health conditions and health care costs. Gen Hosp Psychiatry. 2017 05; 46:79-87. PMID: 28622822.
      Citations:    
    45. Campbell CI, Kline-Simon AH, Von Korff M, Saunders KW, Weisner C. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy. Subst Use Misuse. 2017 08 24; 52(10):1283-1291. PMID: 28346056.
      Citations:    
    46. Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf. 2017 May; 26(5):509-517. PMID: 28074520.
      Citations:    
    47. Lui CK, Sterling SA, Chi FW, Lu Y, Campbell CI. Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes. Addict Behav. 2017 05; 68:45-51. PMID: 28088743.
      Citations:    
    48. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med. 2017 Jan/Feb; 11(1):3-9. PMID: 27610582.
      Citations:    
    49. Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82. PMID: 27749602.
      Citations:    
    50. Campbell CI, Sterling S, Chi FW, Kline-Simon AH. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 Nov 01; 168:1-7. PMID: 27606492.
      Citations:    
    51. Janoff SL, Perrin NA, Coplan PM, Chilcoat HD, Campbell CI, Green CA. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. BMC Pharmacol Toxicol. 2016 05 14; 17(1):21. PMID: 27177423.
      Citations:    
    52. Satre DD, Parthasarathy S, Altschuler A, Silverberg MJ, Storholm E, Campbell CI. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 07; 106(7):1211-3. PMID: 27077361.
      Citations:    
    53. Parthasarathy S, Campbell CI. High-Deductible Health Plans: Implications for Substance Use Treatment. Health Serv Res. 2016 10; 51(5):1939-59. PMID: 26840191.
      Citations:    
    54. Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, Pating D, Campbell CI, Lu YW, Sterling SA. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract. 2015 Nov 19; 10:26. PMID: 26585638.
      Citations:    
    55. LeResche L, Saunders K, Dublin S, Thielke S, Merrill JO, Shortreed SM, Campbell C, Von Korff MR. Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain. J Womens Health (Larchmt). 2015 Aug; 24(8):629-35. PMID: 26153668.
      Citations:    
    56. Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, Weisner CC, Korff MV. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. 2014 Feb; 30(2):93-101. PMID: 23535150.
      Citations:    
    57. Chi FW, Sterling S, Campbell CI, Weisner C. 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity. Subst Abus. 2013; 34(1):33-42. PMID: 23327502.
      Citations:    
    58. Merrill JO, Von Korff M, Banta-Green CJ, Sullivan MD, Saunders KW, Campbell CI, Weisner C. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012 Nov-Dec; 34(6):581-7. PMID: 22959422.
      Citations:    
    59. Howe CQ, Sullivan MD, Saunders KW, Merrill JO, Banta-Green CJ, Weisner C, Campbell CI, Von Korff M. Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain. Clin J Pain. 2012 Sep; 28(7):561-6. PMID: 22699127.
      Citations:    
    60. Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012 Jul-Aug; 10(4):304-11. PMID: 22778118.
      Citations:    
    61. Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell CI. 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):124-30. PMID: 22633367.
      Citations:    
    62. Ramirez R, Hinman A, Sterling S, Weisner C, Campbell C. Peer influences on adolescent alcohol and other drug use outcomes. J Nurs Scholarsh. 2012 Mar; 44(1):36-44. PMID: 22339982.
      Citations:    
    63. Chi FW, Campbell CI, Sterling S, Weisner C. Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan. Addiction. 2012 May; 107(5):933-42. PMID: 22151625.
      Citations:    
    64. Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012 Mar; 13(3):266-75. PMID: 22285611.
      Citations:    
    65. Valkanoff TA, Kline-Simon AH, Sterling S, Campbell C, Von Korff M. Functional disability among chronic pain patients receiving long-term opioid treatment. J Soc Work Disabil Rehabil. 2012; 11(2):128-42. PMID: 22630601.
      Citations:    
    66. Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell CI, Merrill JO, Sullivan MD, Banta-Green CJ, Von Korff M, Weisner C. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012 Jan; 28(1):39-46. PMID: 21677568.
      Citations:    
    67. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011 Jun; 152(6):1256-62. PMID: 21296498.
      Citations:    
    68. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von Korff M. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7. PMID: 20724688.
      Citations:    
    69. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19; 152(2):85-92. PMID: 20083827.
      Citations:    
    70. Satre DD, Campbell CI, Gordon NS, Weisner C. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76. PMID: 20565045.
      Citations:    
    71. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1166-75. PMID: 19718704.
      Citations:    
    72. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, Rutter CM, Weisner C, Banta-Green C, Campbell C, Von Korff M. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009 Nov-Dec; 31(6):564-70. PMID: 19892215.
      Citations:    
    73. Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009 Oct; 145(3):287-93. PMID: 19581051.
      Citations:    
    74. Sterling S, Chi F, Campbell C, Weisner C. Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res. 2009 Aug; 33(8):1417-29. PMID: 19413644.
      Citations:    
    75. Chi FW, Kaskutas LA, Sterling S, Campbell CI, Weisner C. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009 Jun; 104(6):927-39. PMID: 19344442.
      Citations:    
    76. Campbell CI, Alexander JA, Lemak CH. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72. PMID: 19038526.
      Citations:    
    77. Campbell CI, Chi F, Sterling S, Kohn C, Weisner C. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9. PMID: 19010600.
      Citations:    
    78. Von Korff M, Korff MV, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner C. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008 Jul-Aug; 24(6):521-7. PMID: 18574361.
      Citations:    
    79. Campbell CI, Wells R, Alexander JA, Jiang L, Nahra TA, Lemak CH. Tailoring of outpatient substance abuse treatment to women, 1995-2005. Med Care. 2007 Aug; 45(8):775-80. PMID: 17667312.
      Citations:    
    80. Alexander JA, Nahra TA, Lemak CH, Pollack H, Campbell CI. Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005. J Subst Abuse Treat. 2008 Apr; 34(3):282-92. PMID: 17600653.
      Citations:    
    81. Wells R, Lemak CH, Alexander JA, Nahra TA, Ye Y, Campbell CI. Do licensing and accreditation matter in outpatient substance abuse treatment programs? J Subst Abuse Treat. 2007 Jul; 33(1):43-50. PMID: 17588488.
      Citations:    
    82. Campbell CI, Weisner C, Sterling S. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50. PMID: 16549294.
      Citations:    
    83. Campbell CI, Alexander JA. Availability of services for women in outpatient substance abuse treatment: 1995-2000. J Behav Health Serv Res. 2006 Jan; 33(1):1-19. PMID: 16636905.
      Citations:    
    84. Campbell CI, Alexander JA. Health services for women in outpatient substance abuse treatment. Health Serv Res. 2005 Jun; 40(3):781-810. PMID: 15960691.
      Citations:    
    85. Alexander JA, Lemak CH, Campbell CI. Changes in managed care activity in outpatient substance abuse treatment organizations, 1995-2000. J Behav Health Serv Res. 2003 Oct-Dec; 30(4):369-81. PMID: 14593661.
      Citations:    
    86. Lemak CH, Alexander JA, Campbell C. Administrative burden and its implications for outpatient substance abuse treatment organizations. Psychiatr Serv. 2003 May; 54(5):705-11. PMID: 12719502.
      Citations:    
    87. Campbell CI, Alexander JA. Culturally competent treatment practices and ancillary service use in outpatient substance abuse treatment. J Subst Abuse Treat. 2002 Apr; 22(3):109-19. PMID: 12039613.
      Citations:    
    Concepts (246)
    Explore
    _
    Co-Authors (25)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _
    -->

    © 2022 Kaiser Permanente